New Delhi, Jan. 24 -- Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Eastview, close Tarrytown, New York. The Company is known for commercializing drugs for eye disorders, high low-thickness lipoprotein (LDL) cholesterol, and an allergic or skin inflammatory condition and has product competitors being developed in different regions, including rheumatoid joint pain, asthma, atopic dermatitis, torment, malignant growth, and irresistible ailments. The Company's marketed products incorporate EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (Ziv-aflibercept) Injection for ...